Literature DB >> 8630498

Pendred syndrome maps to chromosome 7q21-34 and is caused by an intrinsic defect in thyroid iodine organification.

V C Sheffield1, Z Kraiem, J C Beck, D Nishimura, E M Stone, M Salameh, O Sadeh, B Glaser.   

Abstract

Exactly 100 years ago, in 1896, Pendred first described the association of congenital deafness with thyroid goitre (MM#274600). The incidence of Pendred syndrome is estimated at 7.5-10/100,000, and may be responsible for as much as 10% of hereditary deafness. The cause of the congenital deafness in Pendred syndrome is obscure, although a Mondini type malformation of the cochlea exists in some patients. The reason for the association between the thyroid and cochlear defects is similarly obscure, leading some investigators to suggest that the two recessive defects may be occurring together by chance in highly consanguineous families. An in vivo defect in thyroid iodine organification in Pendred syndrome patients has been reported. However, the molecular basis of this defect is unknown and the presence of an intrinsic thyroidal defect has not been conclusively demonstrated. We have adopted a genetic linkage study as a first step towards identifying the gene. The availability of an inbred Pendred syndrome kindred allowed us to utilize an efficient DNA pooling strategy to perform a genome-wide linkage search for the disease locus. In this way, we have mapped the disease locus to an approximately 9-cM interval between GATA23F5 and D7S687 on chromosome 7. In addition, we demonstrate an intrinsic thyroid iodine organification defect in a patient's thyroid cells as the cause of the thyroid dysfunction.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8630498     DOI: 10.1038/ng0496-424

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  21 in total

1.  Engineered pendrin protein, an anion transporter and molecular motor.

Authors:  Jie Tang; Jason L Pecka; Xiaodong Tan; Kirk W Beisel; David Z Z He
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

2.  Association mapping of disease loci, by use of a pooled DNA genomic screen.

Authors:  L F Barcellos; W Klitz; L L Field; R Tobias; A M Bowcock; R Wilson; M P Nelson; J Nagatomi; G Thomson
Journal:  Am J Hum Genet       Date:  1997-09       Impact factor: 11.025

3.  Further refinement of Pendred syndrome locus by homozygosity analysis to a 0.8 cM interval flanked by D7S496 and D7S2425.

Authors:  M Mustapha; S T Azar; Y B Moglabey; M Saouda; G Zeitoun; J Loiselet; R Slim
Journal:  J Med Genet       Date:  1998-03       Impact factor: 6.318

Review 4.  Pendred syndrome.

Authors:  W Reardon; R C Trembath
Journal:  J Med Genet       Date:  1996-12       Impact factor: 6.318

5.  Pendred syndrome: evidence for genetic homogeneity and further refinement of linkage.

Authors:  E Gausden; B Coyle; J A Armour; R Coffey; A Grossman; G R Fraser; R M Winter; M E Pembrey; P Kendall-Taylor; D Stephens; L M Luxon; P D Phelps; W Reardon; R Trembath
Journal:  J Med Genet       Date:  1997-02       Impact factor: 6.318

Review 6.  Regulation of transport in the connecting tubule and cortical collecting duct.

Authors:  Alexander Staruschenko
Journal:  Compr Physiol       Date:  2012-04       Impact factor: 9.090

7.  Calcium oxalate stone formation in the inner ear as a result of an Slc26a4 mutation.

Authors:  Amiel A Dror; Yael Politi; Hashem Shahin; Danielle R Lenz; Silvia Dossena; Charity Nofziger; Helmut Fuchs; Martin Hrabé de Angelis; Markus Paulmichl; Steve Weiner; Karen B Avraham
Journal:  J Biol Chem       Date:  2010-05-04       Impact factor: 5.157

Review 8.  Thyroid iodide efflux: a team effort?

Authors:  Peying Fong
Journal:  J Physiol       Date:  2011-10-10       Impact factor: 5.182

9.  Delayed diagnosis of Pendred syndrome.

Authors:  Natalie Smith; Jean-Marie U-King-Im; Janaka Karalliedde
Journal:  BMJ Case Rep       Date:  2016-09-12

10.  Pendred syndrome among patients with congenital hypothyroidism detected by neonatal screening: identification of two novel PDS/SLC26A4 mutations.

Authors:  Karolina Banghova; Eva Al Taji; Ondrej Cinek; Dana Novotna; Radka Pourova; Jirina Zapletalova; Olga Hnikova; Jan Lebl
Journal:  Eur J Pediatr       Date:  2007-09-18       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.